Should I Buy NUKK? NUKK 2026 Analysis

Should You Buy Nukkleus Inc (NUKK) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

2.060

1 Day change

8.42%

52 Week Range

26.210

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient investor: price is breaking down below near-term support while trend signals remain firmly bearish.
Oversold RSI (~15) can produce a reflex bounce, but there is no Intellectia signal confirming a tradable entry today, so odds favor continued weakness/whipsaw.
Fundamentals are too unstable (latest quarter revenue at 0) to justify “buy now” on a dip.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Technical Analysis

Trend: Bearish (SMA_200 > SMA_20 > SMA_5), indicating persistent downside structure.
Momentum: MACD histogram -0.0169 and negatively expanding → bearish momentum is strengthening, not stabilizing.
Mean-reversion risk: RSI_6 at 14.959 (deep oversold) suggests a bounce is possible, but oversold alone is not a buy signal.
Levels: Current price ~1.995 is below S1 (2.025) → failed support; next support S2 ~1.734. Upside hurdles: Pivot 2.495, then R1 2.965.
Pattern-based expectation: modest positive drift projected over 1 week/month, but near-term probability is weak (only ~40% chance next day with small expected move).

Positive Catalysts

Subsidiary B. Rimon Agencies Inc. secured multi-year contracts worth ~$4.1M supporting Israel’s missile defense/national security—potential revenue visibility and event-driven interest.

Neutral/Negative Catalysts

with bearish moving averages and worsening MACD → downside continuation risk toward ~1.
- Latest reported quarter shows revenue dropped to 0 (-100% YoY), undermining confidence in business stability.

Financial Performance

Latest quarter: 2025/Q3.
Revenue: 0 (down -100% YoY) → severe top-line deterioration.
Net income: -16,365,492 (loss; “improved” YoY but still deeply negative).
EPS: -2.01 (improved YoY, but remains meaningfully negative).
Gross margin: 0 (down -100% YoY), consistent with the revenue collapse and/or lack of operating throughput.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target updates were provided, implying limited/absent Wall Street coverage.
Wall Street-style pros (based on available info): defense/security contract win could support future revenue.
Wall Street-style cons (based on available info): revenue collapse to zero and continued losses outweigh the single contract headline for a “buy now” decision.
Politicians/congress: No recent congress trading data available.

Analyst Rating

Wall Street analysts forecast NUKK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUKK is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold